Saudi Space Agency Honors KFSHRC's Role In 'Saudi Towards Space' Mission

The CEO of the Saudi Space Agency, Dr. Mohammed Altamimi, honoured King Faisal Specialist Hospital and Research Centre (KFSHRC) for its significant participation in conducting four cell biology research experiments in space. This was part of the mission involving Saudi astronauts Rayyanah Barnawi and Ali Alqarni to the International Space Station (ISS). The ceremony, hosted by the Saudi Space Agency, marked the first anniversary of the "Saudi Towards Space" mission and was attended by several senior officials.

KFSHRC conducted four research experiments on the ISS. These included testing immune cell response to inflammation in space, monitoring gene activity in inflamed immune cells over time, observing changes in mRNA lifespan between space and Earth, and simulating inflammatory response to drug treatment using an immune cell model. These experiments aim to provide insights into human health in space and how the body responds to extraterrestrial variables.

Dr. Khalid Abu Khabar, lead researcher and Molecular Biomedicine Chairman at KFSHRC, expressed pride in their scientific achievements. He noted that their contribution to "Saudi Towards Space" represents a milestone in their research journey. Dr. Abu Khabar highlighted that the drug evaluation platform used in these experiments is a unique innovation that significantly contributes to KFSHRC's scientific achievements.

Future Prospects

Efforts are underway to secure patents for this platform in multiple countries. The platform has potential applications for various human diseases both in space and on Earth, including autoimmune disorders, chronic inflammatory conditions, microbial infections, muscle and heart diseases, and certain neurological conditions. Dr. Wijdan Alahmadi emphasized that these research experiments are part of rapid advancements in space medicine.

KFSHRC's Global Recognition

KFSHRC has retained its status as the leading institution in the Kingdom for the second year running and ranks 20th globally among the top 250 academic medical centres worldwide. It is also recognized as the most valuable healthcare brand in the Kingdom and the Middle East in 2024, according to Brand Finance. Additionally, Newsweek Magazine has ranked it among the world's top 250 hospitals.

The recognition of KFSHRC's contributions underscores its role in advancing space medicine research and its commitment to innovative and advanced research that strengthens Saudi Arabia's position in this field.

With inputs from SPA